About me
I cut my teeth on medicinal chemistry, NMR spectroscopy and molecular modeling (CDK7 inhibitors, tubulin inhibitors dictyostatin and discodermolide) under the outstanding mentorship of Dennis Liotta and Jim Snyder at Emory University. Postdoc positions at Sanofi and the University of North Carolina (nuclear receptor library design, AHR modeling) led to a productive stint designing macrocycle drugs (IL-17 inhibitors) for inflammation and cancer at Ensemble Therapeutics in Cambridge, MA. Explorations in tripartite macrocycle complex design (KRAS G12C) continued at Warp Drive Bio in Cambridge. I followed my continued interests in oncology drug design at Revolution Medicines in Redwood City, CA where I worked on SHP2 inhibitors for cancer and did some business development for outsourcing DEL libraries.
Broader interests led me into the world of product development for automated medicinal chemistry cloud labs at Transcriptic/Strateos in Menlo Park, CA where I was the product manager for a multimillion-dollar drug discovery cloud lab focused on analytical and synthetic chemistry and assays. The opportunity to wear these different hats culminated in a rewarding tenure as head of product at OpenEye Scientific, where I had the privilege of leading an amazing team of designers, scientists, and product managers working on a Swiss army knife-like drug design cloud platform named Orion.
With my experience in drug discovery, platforms and product development, I am looking forward to the next exciting opportunity. I’m open to opportunities in medicinal and computational chemistry, venture capital and business development.
Other interests: I am also an experienced and recognized science writer and have been writing a well-recognized blog called "The Curious Wavefunction" for twenty years. I have written for Scientific American for two years, am a monthly columnist for 3 Quarks Daily, and was an invited journalist at the Lindau Meeting of Nobel Laureates. My main interests are in the history and philosophy of science and technology.
Subscribe to get full access to the newsletter and publication archives.
Stay up-to-date
Never miss an update—every new post is sent directly to your email inbox. For a spam-free, ad-free reading experience, plus audio and community features, get the Substack app.
Join the crew
Be part of a community of people who share your interests. Participate in the comments section, or support this work with a subscription.
To learn more about the tech platform that powers this publication, visit Substack.com.
